Evidence map›Paper›PMID 37609342›Full record

ArticleResearch square2023

Machine Learning Ensemble Directed Engineering of Genetically Encoded Fluorescent Calcium Indicators.

Sarah J Wait, Michael Rappleye, Justin Daho Lee, Marc Exposit Goy, Netta Smith, Andre Berndt

Abstract readPreprint
In one paragraph

Article in Research square, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Sarah J WaitMolecular Engineering and Sciences Institute, University of Washington, Seattle, WA.
Michael RappleyeInstitute of Stem Cell and Regenerative Medicine, University of Washington, Seattle, WA.
Justin Daho LeeMolecular Engineering and Sciences Institute, University of Washington, Seattle, WA.
Marc Exposit GoyMolecular Engineering and Sciences Institute, University of Washington, Seattle, WA.
Netta SmithDepartment of Bioengineering, University of Washington, Seattle, WA.
Andre BerndtMolecular Engineering and Sciences Institute, University of Washington, Seattle, WA.

Funding

University of Washington Center of Excellence in Opioid Addiction ResearchP30DA048736 · NIDA · UNIVERSITY OF WASHINGTON · PI Charles Chavkin · 2019 to 2026
$13.0M
Structure-guided and high-throughput engineering of genetically encoded sensors for reactive oxygen speciesR01GM139850 · NIGMS · UNIVERSITY OF WASHINGTON · PI BERNDT, ANDRE · 2021 to 2024
$1.6M
Deciphering biased agonistic activation of mu-opioid receptor by novel optogenetic hydrogen peroxide sensorF31DA056121 · NIDA · UNIVERSITY OF WASHINGTON · PI LEE, JUSTIN · 2022 to 2024
$85k
NIDA NIH HHS F31 DA056121NIDA NIH HHS P30 DA048736NIGMS NIH HHS R01 GM139850
6 · The paper itself

Abstract

In this study, we focused on the transformative potential of machine learning in the engineering of genetically encoded fluorescent indicators (GEFIs), protein-based sensing tools that are critical for real-time monitoring of biological activity. GEFIs are complex proteins with multiple dynamic states, rendering optimization by trial-and-error mutagenesis a challenging problem. We applied an alternative approach using machine learning to predict the outcomes of sensor mutagenesis by analyzing established libraries that link sensor sequences to functions. Using the GCaMP calcium indicator as a scaffold, we developed an ensemble of three regression models trained on experimentally derived GCaMP mutation libraries. We used the trained ensemble to perform an in silico functional screen on 1423 novel, uncharacterized GCaMP variants. As a result, we identified the novel ensemble-derived GCaMP (eGCaMP) variants, eGCaMP and eGCaMP+, that achieve both faster kinetics and larger fluorescent responses upon stimulation than previously published fast variants. Furthermore, we identified a combinatorial mutation with extraordinary dynamic range, eGCaMP2+, that outperforms the tested 6th, 7th, and 8th generation GCaMPs. These findings demonstrate the value of machine learning as a tool to facilitate the efficient pre-screening of mutants for functional characteristics. By leveraging the learning capabilities of our ensemble, we were able to accelerate the identification of promising mutations and reduce the experimental burden associated with trial-and-error mutagenesis. Overall, these findings have significant implications for optimizing GEFIs and other protein-based tools, demonstrating the utility of machine learning as a powerful asset in protein engineering.

Identifiers

PMID37609342
PMCPMC10441480

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.